At the 23rd Annual European Association of Urology (EAU) Congress, results were presented which added evidence that LevitraŽ (vardenafil HCI) works very well in men with dyslipidemia.(1) The double-blind, placebo-controlled trial in about 400 men showed that LevitraŽ significantly improved the ability of men with erectile dysfunction (ED) and high cholesterol, to achieve and maintain an erection for successful sexual intercourse.(2) The trial, led by Dr.

More: continued here

This entry was posted on Sunday, April 6th, 2008 at 1:04 am and is filed under Cholesterol. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.